These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6800010)

  • 1. [Retrospective study of Graves ophthalmopathy in relation to thyroid treatment (author's transl)].
    Franco Casique JJ; Bolanños Gil F; Llamas Esperón G; Maisterrena JA
    Rev Invest Clin; 1981; 33(4):361-4. PubMed ID: 6800010
    [No Abstract]   [Full Text] [Related]  

  • 2. The vanishing surgical treatment of Graves' disease: review of current literature and experience with 50 patients.
    Argov S; Duek D
    Curr Surg; 1982; 39(3):158-62. PubMed ID: 7047083
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of the hyperthyroidism of Graves-Basedow disease with thiocarbamides (author's transl)].
    Sosa J; Bolaños F; González O; Valverde C; Maisterrena J
    Rev Invest Clin; 1977; 29(3):227-30. PubMed ID: 578998
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of endocrine ophthalmopathy].
    Pfannenstiel P; Utech C; Wulle KG
    Dtsch Med Wochenschr; 1986 Aug; 111(35):1331-3. PubMed ID: 3755678
    [No Abstract]   [Full Text] [Related]  

  • 5. [Management of hyperthyreosis of the Basedow disease type].
    Pickardt CR
    Dtsch Med Wochenschr; 1978 Jun; 103(23):959-61. PubMed ID: 580603
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graves' ophthalmopathy and 131I therapy.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Basedow's disease].
    Scheidegger K
    Schweiz Rundsch Med Prax; 1993 Aug; 82(32):840-4. PubMed ID: 7690495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Graves' disease].
    Willhauck MJ; Spitzweg C
    MMW Fortschr Med; 2008 Sep; 150(36-37):31-5. PubMed ID: 18988333
    [No Abstract]   [Full Text] [Related]  

  • 10. Endocrine ophthalmopathy and radioiodine therapy.
    Karlsson FA
    Acta Oncol; 2006; 45(8):1046-50. PubMed ID: 17118837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Graves' disease.
    Utiger R
    N Engl J Med; 1978 Mar; 298(12):681-2. PubMed ID: 580106
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of Graves' ophthalmopathy.
    Beck RW; DiLoreto DA
    N Engl J Med; 1990 Apr; 322(15):1088-9. PubMed ID: 2320076
    [No Abstract]   [Full Text] [Related]  

  • 13. Surgical management of Graves disease in childhood and adolescence: an institutional experience.
    Sherman J; Thompson GB; Lteif A; Schwenk WF; van Heerden J; Farley DR; Kumar S; Zimmerman D; Churchward M; Grant CS
    Surgery; 2006 Dec; 140(6):1056-61; discussion 1061-2. PubMed ID: 17188157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with iodine radioisotopes and thyroid-associated ophthalmopathy in Graves' disease].
    Rasmussen AK; Feldt-Rasmussen UF
    Ugeskr Laeger; 1999 Oct; 161(43):5933-4. PubMed ID: 10778332
    [No Abstract]   [Full Text] [Related]  

  • 15. [Histomorphometric study of lymphocyte population in thyroid in Graves' disease after treatment (author's transl)].
    Franc B; Barres D; Baglin C; Garnier H; Mignot M; Mignot J
    Ann Pathol; 1981; 1(1):90-4. PubMed ID: 7018512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term evolution of immunologic and thyroid function in Graves disease according different therapeutic options].
    Campos Pastor MM; Fernández Soto ML; Escobar-Jiménez F; Barredo Acedo F; Ruiz de Almodóvar M
    Med Clin (Barc); 1994 Apr; 102(12):446-50. PubMed ID: 7516033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Graves' hyperthyroidism: evidence-based and emerging modalities.
    Hegedüs L
    Endocrinol Metab Clin North Am; 2009 Jun; 38(2):355-71, ix. PubMed ID: 19328416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioactive iodine in the treatment of Graves' disease.
    Al-Kaabi JM; Hussein SS; Bukheit CS; Woodhouse NJ; Elshafie OT; Bererhi H
    Saudi Med J; 2002 Sep; 23(9):1049-53. PubMed ID: 12370710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basedow's disease: medical treatment].
    Gnudi A
    Minerva Endocrinol; 1987; 12(1):45-7. PubMed ID: 3587200
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
    Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.